EMREN, S. V. Et Al. 2020. Assessment of the compatibility of the real-world nonvalvular atrial fibrillation patients in Turkey with the study population of Phase 3 novel oral anticoagulant trials: An auxiliary study of NOAC-TR. International Journal of the Cardiovascular Academy , vol.6, no.1 , 12-15.

EMREN, S. V., ZOGHİ, M., Karagöz, U., Inci, S., Açiksari, G., BEKAR, L., ... YAPAN EMREN, Z.(2020). Assessment of the compatibility of the real-world nonvalvular atrial fibrillation patients in Turkey with the study population of Phase 3 novel oral anticoagulant trials: An auxiliary study of NOAC-TR. International Journal of the Cardiovascular Academy , vol.6, no.1, 12-15.

EMREN, SADIK Et Al. "Assessment of the compatibility of the real-world nonvalvular atrial fibrillation patients in Turkey with the study population of Phase 3 novel oral anticoagulant trials: An auxiliary study of NOAC-TR," International Journal of the Cardiovascular Academy , vol.6, no.1, 12-15, 2020

EMREN, SADIK V. Et Al. "Assessment of the compatibility of the real-world nonvalvular atrial fibrillation patients in Turkey with the study population of Phase 3 novel oral anticoagulant trials: An auxiliary study of NOAC-TR." International Journal of the Cardiovascular Academy , vol.6, no.1, pp.12-15, 2020

EMREN, S. V. Et Al. (2020) . "Assessment of the compatibility of the real-world nonvalvular atrial fibrillation patients in Turkey with the study population of Phase 3 novel oral anticoagulant trials: An auxiliary study of NOAC-TR." International Journal of the Cardiovascular Academy , vol.6, no.1, pp.12-15.

@article{article, author={SADIK VOLKAN EMREN Et Al. }, title={Assessment of the compatibility of the real-world nonvalvular atrial fibrillation patients in Turkey with the study population of Phase 3 novel oral anticoagulant trials: An auxiliary study of NOAC-TR}, journal={International Journal of the Cardiovascular Academy}, year=2020, pages={12-15} }